(2) Sikiric P, Seiwerth S, Rucman R, Kolenc D, et al
Schluckebier G
Welcome back to my deep dive on this amazing longevity peptide
(2) developing combination therapies for specific pathological subtypes, including potential synergistic benefits with mitochondria-targeted antioxidants (e.g., MitoQ) or bile acid modulators (e.g., ursodeoxycholic acid, UDCA) in MASH patients with prominent ballooning degeneration or cholestatic features
It has been explored for its ability to: Support tissue repair Reduce inflammation Promote blood vessel formation (angiogenesis) Enhance collagen production These effects make it relevant in conditions involving joints, tendons, ligaments, nerves, and the gut
doi:10.1074/jbc.M114.588913 Green DR, Galluzzi L, Kroemer G (2014) Cell biology